Global Research Nonprofit CureDuchenne Joins Pfizer to Host Free Webinar on Pfizer?s Advancement to Phase III Gene Therapy Clinical Trial

NEWPORT BEACH, Calif.–(BUSINESS WIRE)–CureDuchenne, the leading global nonprofit focused on finding a cure for Duchenne muscular dystrophy, will co-host a free webinar with Pfizer to discuss their advancement to Phase III Clinical Trial for PF-06939926. The webinar will take place on Wednesday, March 11 at 11:00am PT/2:00pm ET and features Dr. Beth Belluscio, Pfizer Global Clinical Lead for Rare Neurological Disorders, discussing the Phase 3 study of PF-06939926, a gene therapy for Duchenne m